miR-208 inhibitors (miRagen)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamemiR-208 inhibitors (miRagen)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsObesityMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesViridian Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesViridian Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsObesityMetabolic Diseases

Other Information

ATC CodeN/A